These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

61 related items for PubMed ID: 15595971

  • 1. Effect of a new angiotensin converting enzyme inhibitor MK 421 and its lysine analogue on the components of the renin system in healthy subjects. 1981.
    Brunner DB, Desponds G, Biollaz J, Keller I, Ferber F, Gavras H, Brunner HR, Schelling JL.
    Br J Clin Pharmacol; 2004 Dec; 58(7):S778-84; discussion S785-7. PubMed ID: 15595971
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effects on plasma angiotensin-converting enzyme activity and circulating renin of lisinopril and enalapril alone and in combination with propranolol in healthy volunteers.
    Hansen EF, Bendtsen F, Henriksen JH.
    Pharmacol Toxicol; 1999 Mar; 84(3):110-4. PubMed ID: 10193670
    [Abstract] [Full Text] [Related]

  • 5. Comparison of suppression of the circulating and vascular renin-angiotensin system by enalapril versus trandolapril in chronic heart failure.
    Jorde UP, Vittorio TJ, Dimayuga CA, Homma S, Rizkala A, Le Jemtel TH, Katz SD.
    Am J Cardiol; 2004 Dec 15; 94(12):1501-5. PubMed ID: 15589004
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Beneficial effects of Renin-Angiotensin system blockers on testicular steroidogenesis.
    Alves-Pereira JL, Frantz ED, da Fonte Ramos C.
    J Urol; 2014 Dec 15; 192(6):1878-83. PubMed ID: 24880039
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of angiotensin converting enzyme from sheep tissues by captopril, lisinopril and enalapril.
    Udupa EG, Rao NM.
    Indian J Biochem Biophys; 1997 Dec 15; 34(6):524-8. PubMed ID: 9594434
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effect of chronic angiotensin II type I receptor antagonism and angiotensin converting enzyme inhibition on plasma fibrinolytic variables in patients with heart failure.
    Davie AP, Rumley A, Lowe GD, McMurray JJ.
    Thromb Haemost; 2001 Dec 15; 86(6):1585-6. PubMed ID: 11776334
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Renin-angiotensin system inhibitors as antihypertrophic agents.
    Ianosi-Irimie M, Deutsch P.
    Pharmazie; 2000 Aug 15; 55(8):629. PubMed ID: 10989849
    [No Abstract] [Full Text] [Related]

  • 15. ACE inhibition or angiotensin receptor blockade: impact on potassium in renal failure.
    Hollenberg NK.
    Curr Hypertens Rep; 2001 Jun 15; 3(3):178. PubMed ID: 11421228
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Pharmacodynamic effects of C-domain-specific ACE inhibitors on the renin-angiotensin system in myocardial infarcted rats.
    Sharp S, Poglitsch M, Zilla P, Davies NH, Sturrock ED.
    J Renin Angiotensin Aldosterone Syst; 2015 Dec 15; 16(4):1149-58. PubMed ID: 25757657
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.